Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 698-698.
• Orginal Article • Previous Articles Next Articles
ZHANG Zhaohui, DU Hui, QU Bin*
Received:2019-01-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
ZHANG Zhaohui, DU Hui, QU Bin. One Case of Allergic Shock Induced by Atevacaine Epinephrine Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 698-698.
Add to citation manager EndNote|Ris|BibTeX
| [1] 江永贤,李根,王涵,等. 王玉兰注射用戈那瑞林致过敏性休克1例[J].中国药物警戒,2018,15(8):504-505. [2] 赵世丹,鲁仲平. 影响个例药品不良反应报告评价的因素[J].中国药物警戒,2012,9(9):553-555. [3] 谢桂英,罗华强,裴切艳,等. 复方盐酸阿替卡因注射液致过敏性休克1例[J].实用医技杂志,2014,21(6): 695-696. [4] 夏丽华,许志红,王跃进. 盐酸阿替卡因肾上腺素注射液过敏1例[J].现代口腔医学杂志,2008,22(6):16. [5] 梅帅,朱辛奕,刘境华. 盐酸阿替卡因肾上腺素注射液过敏患者1例报告[J].中国民康医药2015:26(25):128. [6] 朱翔. 可疑焦亚硫酸钠过敏反应1例[J].中国乡村医学,2014,21(19):49. [7] 林瑶,薛晓娟,高亚,等. 阿替卡因肾上腺素注射液致过敏性休克1例[C]//中华医学会. 中华医学会临床药学分会2014年全国学术会议. 2014:39-40. [8] 李文梅. 阿替卡因肾上腺素注射液引起过敏反应1例[J]. 中国疗养医学,2012,21(2):170. [9] 余磊. 阿替卡因肾上腺素注射液引起过敏反应1例[J].海峡医学, 2012,24(1):256-257. [10] 王少坤,闫百灵,李薇,等. 复方盐酸阿替卡因注射液致急性喉头水肿窒息1例[J].中国老年学杂志,2012,32:(16):3548. [11] 景藏. 阿替卡因肾上腺素注射液浸润麻醉致面瘫1例[J]. 口腔医学,2005,25(6):350. [12] 郑利光,秦满牛,桂田. 阿替卡因肾上腺素注射液致局部组织坏死1例[J].中国药事,2008,22(9): 840. [13] 钟媛. 探讨优质护理服务应用在老年肺心病患者中对心理和生活质量的影响效果[J]. 世界最新医学信息文摘,2018,18(86):202. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
